Fireside Chat: A Discussion on the Orphan Drug Revolution

1:00 PM - 2:00 PM (PDT), Monday, June 13, 2022 ・ Session Room 10

Jim Geraghty, a board director of five NASDAQ-listed biotech companies and author, joins a conversation with Paul Hastings, CEO, Nkarta Therapeutics and Chair, of the BIO Board of Directions. The new book, “Inside the Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology”, explores the origin of the Orphan Drug Act and the impact nearly 40 years later. These biotech leaders will discuss the importance of the legislation to scientists, advocates, and entrepreneurs, BIO’s advocacy for this policy and subsequent developments, and the challenges facing orphan drugs today.

Speaker
photo
Chairman
BVGH Guests